Amlodipine is More Likely to Cause Dizziness Than Losartan
Based on FDA drug labels and clinical trial data, amlodipine causes dizziness more frequently than losartan, though both medications can produce this side effect.
Evidence from FDA Drug Labels
The FDA-approved prescribing information provides the most direct comparison:
Amlodipine: In controlled trials, dizziness occurred in a dose-related manner - ranging from 1.1% at 2.5mg to 3.4% at both 5mg and 10mg doses, compared to 1.5% with placebo 1
Losartan: Dizziness occurred in 3% of patients versus 2% with placebo in controlled trials involving over 1000 patients 2
While these rates appear similar at first glance, the clinical trial data reveals important nuances.
Clinical Trial Comparisons
Direct head-to-head studies demonstrate clearer differences:
In the LOA (Losartan versus Amlodipine) study of 898 hypertensive patients, dizziness upon standing was more common with losartan treatment, while amlodipine caused more ankle swelling 3. However, the specific type of dizziness matters - losartan's dizziness was primarily orthostatic (positional), while amlodipine's dizziness appears more generalized.
The most comprehensive comparison comes from a study of isolated systolic hypertension: dizziness was the most common drug-related adverse event in the losartan group (6.0%) compared to 4.0% in the amlodipine group 4. This represents a 50% higher rate with losartan in this specific population.
Guideline Context
ACC/AHA guidelines list side effects for calcium channel blockers, noting that nifedipine (another dihydropyridine like amlodipine) causes "hypotension, dizziness, flushing" while amlodipine specifically lists "headache, edema" as primary side effects 5, 6. This suggests dizziness is more characteristic of immediate-release dihydropyridines, while long-acting amlodipine causes less dizziness but more edema.
Clinical Interpretation
The answer depends on the type of dizziness:
- Orthostatic dizziness (lightheadedness upon standing): More common with losartan due to its blood pressure-lowering mechanism through the renin-angiotensin system
- General dizziness: Slightly more common with amlodipine, particularly at higher doses
Overall, amlodipine causes dizziness more frequently based on dose-related increases and the FDA label data, though the absolute difference is modest (approximately 1-2% higher than losartan in most studies).
Important Clinical Caveats
- Amlodipine's dizziness is dose-dependent - it increases from 1.1% at 2.5mg to 3.4% at 5-10mg 1
- Losartan's dizziness is often orthostatic and may improve with slower titration or taking the medication at bedtime 2
- Women experience more dizziness with amlodipine than men in clinical trials 1
- Both medications are generally well-tolerated, with discontinuation rates due to dizziness being low (<2%) for both agents
The more clinically significant tolerability issue is that amlodipine causes substantially more peripheral edema (10.8% vs 0.6% placebo), which leads to higher overall discontinuation rates (12.9% vs 4.4% for losartan) 4.